HRP20010013A2 - Novel poly (adp-ribose)polymerase gene - Google Patents

Novel poly (adp-ribose)polymerase gene

Info

Publication number
HRP20010013A2
HRP20010013A2 HR20010013A HRP20010013A HRP20010013A2 HR P20010013 A2 HRP20010013 A2 HR P20010013A2 HR 20010013 A HR20010013 A HR 20010013A HR P20010013 A HRP20010013 A HR P20010013A HR P20010013 A2 HRP20010013 A2 HR P20010013A2
Authority
HR
Croatia
Prior art keywords
parp
adp
poly
seq
sequence
Prior art date
Application number
HR20010013A
Other languages
English (en)
Croatian (hr)
Inventor
Michael Kock
Thomas Hoeger
Burkhard Kroeger
Bernd Otterbach
Wilfried Lubisch
Hans-Georg Lemaire
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP20010013A2 publication Critical patent/HRP20010013A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/0203—NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G01N2333/91142—Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
HR20010013A 1998-06-05 1999-06-04 Novel poly (adp-ribose)polymerase gene HRP20010013A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01
PCT/EP1999/003889 WO1999064572A2 (fr) 1998-06-05 1999-06-04 Genes de poly(adp-ribose)polymerase

Publications (1)

Publication Number Publication Date
HRP20010013A2 true HRP20010013A2 (en) 2001-12-31

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010013A HRP20010013A2 (en) 1998-06-05 1999-06-04 Novel poly (adp-ribose)polymerase gene

Country Status (24)

Country Link
US (3) US7754459B1 (fr)
EP (1) EP1082416B1 (fr)
JP (1) JP2002517231A (fr)
KR (1) KR20010052582A (fr)
CN (1) CN1304446A (fr)
AR (1) AR020326A1 (fr)
AT (1) ATE358175T1 (fr)
AU (1) AU4605999A (fr)
BG (1) BG105018A (fr)
BR (1) BR9910967A (fr)
CA (1) CA2330206C (fr)
CO (1) CO5070700A1 (fr)
DE (1) DE59914280D1 (fr)
ES (1) ES2285842T3 (fr)
HK (1) HK1038591A1 (fr)
HR (1) HRP20010013A2 (fr)
HU (1) HUP0103190A2 (fr)
ID (1) ID27819A (fr)
IL (1) IL139750A0 (fr)
NO (1) NO20006153L (fr)
PL (1) PL345334A1 (fr)
SK (1) SK17892000A3 (fr)
TR (1) TR200003624T2 (fr)
WO (1) WO1999064572A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
WO2000077179A2 (fr) * 1999-06-16 2000-12-21 Icos Corporation Materiaux poly(adp-ribose) polymerase 2 humains et procedes
DE50112961D1 (de) 2000-02-01 2007-10-18 Abbott Gmbh & Co Kg Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
ZA200800907B (en) 2005-07-18 2010-04-28 Bipar Sciences Inc Treatment of cancer
WO2008030883A2 (fr) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Traitement du cancer
CN101534836B (zh) 2006-09-05 2011-09-28 彼帕科学公司 Parp抑制剂在制备治疗肥胖症的药物中的用途
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
AR084894A1 (es) 2011-02-18 2013-07-10 Danisco Composicion de aditivo para pienso
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
SG10201701601WA (en) 2012-08-29 2017-04-27 Sangamo Biosciences Inc Methods and compositions for treatment of a genetic condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) * 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
ID27819A (id) 2001-04-26
US20160010067A1 (en) 2016-01-14
NO20006153L (no) 2001-02-02
ATE358175T1 (de) 2007-04-15
US7754459B1 (en) 2010-07-13
US20110107444A1 (en) 2011-05-05
CN1304446A (zh) 2001-07-18
JP2002517231A (ja) 2002-06-18
AU4605999A (en) 1999-12-30
KR20010052582A (ko) 2001-06-25
SK17892000A3 (sk) 2001-09-11
US9051553B2 (en) 2015-06-09
HUP0103190A2 (hu) 2001-12-28
BG105018A (en) 2001-12-31
PL345334A1 (en) 2001-12-17
IL139750A0 (en) 2002-02-10
DE59914280D1 (en) 2007-05-10
EP1082416B1 (fr) 2007-03-28
WO1999064572A2 (fr) 1999-12-16
HK1038591A1 (zh) 2002-03-22
BR9910967A (pt) 2001-02-13
EP1082416A2 (fr) 2001-03-14
CA2330206C (fr) 2010-04-13
WO1999064572A3 (fr) 2000-06-08
TR200003624T2 (tr) 2001-06-21
ES2285842T3 (es) 2007-11-16
NO20006153D0 (no) 2000-12-04
CO5070700A1 (es) 2001-08-28
CA2330206A1 (fr) 1999-12-16
AR020326A1 (es) 2002-05-08

Similar Documents

Publication Publication Date Title
US9051553B2 (en) Poly(ADP-ribose) polymerase genes
US10538563B2 (en) Rspondins as modulators of angiogenesis and vasculogenesis
AU2001284483B2 (en) Remedies for heart failure
CN101632833A (zh) 一种前列腺癌相关的基因及其用途
JP2002517241A (ja) ヒト受容体チロシンキナーゼ
JP2001503984A (ja) Ｒｈｏ―ＧＴＰａｓｅのグアニン交換因子、およびこれをコードする核酸
TW200831536A (en) Method of diagnosing and treating glioma
US6906179B2 (en) Antibody to SNIP1
US8349576B2 (en) eEF2K assays for identifying compounds that inhibit eEF2K activity
JP4459307B2 (ja) 全身性紅斑性狼瘡を治療するためのペプチド
EP1365018A1 (fr) Function de la sémaphorine CD100 dans la myélination
CA2496234A1 (fr) Kinases 2 induites par des sels et leur utilisation
KR20060036119A (ko) 시노비올린 활성 조절 작용의 검출 방법
MXPA00011567A (en) Poly(adp-ribose)polymerase gene
JPWO2007026969A1 (ja) 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
CZ20004536A3 (cs) Nové poly(ADP-ribóza) polymerázové geny
ZA200100084B (en) Poly(ADP-ribose)polymerase gene.
JPH08502487A (ja) 新規なクラスのｒｐｔｐアーゼ：それらの構造ドメイン及びリガンド
JP2003533226A (ja) 神経細胞のセリンスレオニンプロテインキナーゼ
US20060168667A1 (en) Minibrain homologous proteins involved in the regulation of energy homeostasis
WO2004035082A2 (fr) Proteines impliquees dans la regulation de l'homeostasie energetique
US20040142894A1 (en) Modulation of cellular proliferation
WO2004002513A2 (fr) Proteines impliquees dans la regulation de l'hemostase energetique
WO2005025590A2 (fr) Utilisation d'un produit proteique dg280 dans la prevention et le traitement de troubles metaboliques
WO2006101273A1 (fr) Agent prophylactique et therapeutique contre le cancer

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn